Sara C. Singer

712 total citations
8 papers, 556 citations indexed

About

Sara C. Singer is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Sara C. Singer has authored 8 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Sara C. Singer's work include Cholinesterase and Neurodegenerative Diseases (3 papers), Computational Drug Discovery Methods (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Sara C. Singer is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (3 papers), Computational Drug Discovery Methods (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Sara C. Singer collaborates with scholars based in United States. Sara C. Singer's co-authors include Richard F. Lee, Ronald W. Barrett, Steven E. Cwirla, Balasubramanian Palaniappan, David P. Baccanari, Ann M. Davis, William J. Dower, Peter J. Schatz, Nicholas C. Wrighton and Robert L. Tansik and has published in prestigious journals such as Science, Journal of Biological Chemistry and Biochemical Pharmacology.

In The Last Decade

Sara C. Singer

8 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara C. Singer United States 8 250 136 119 97 67 8 556
Junya Kohroki Japan 14 278 1.1× 49 0.4× 54 0.5× 67 0.7× 80 1.2× 23 492
Rosina Hill United States 19 568 2.3× 57 0.4× 29 0.2× 122 1.3× 60 0.9× 26 1.2k
R.J. Albertini United States 14 430 1.7× 23 0.2× 95 0.8× 111 1.1× 45 0.7× 17 758
R. A. Miller United States 9 241 1.0× 32 0.2× 357 3.0× 239 2.5× 138 2.1× 13 995
Kenneth A. Lord United States 14 389 1.6× 80 0.6× 17 0.1× 78 0.8× 165 2.5× 19 789
Joost P.M. Melis Netherlands 11 379 1.5× 28 0.2× 72 0.6× 35 0.4× 81 1.2× 13 601
E Frankus Germany 8 282 1.1× 211 1.6× 28 0.2× 12 0.1× 42 0.6× 21 773
Silvia Viaggi Italy 15 366 1.5× 14 0.1× 59 0.5× 84 0.9× 73 1.1× 35 664
Ingrid Gemperlein United States 7 214 0.9× 142 1.0× 9 0.1× 42 0.4× 122 1.8× 7 465
I. G. Walker Canada 17 587 2.3× 18 0.1× 55 0.5× 35 0.4× 77 1.1× 42 854

Countries citing papers authored by Sara C. Singer

Since Specialization
Citations

This map shows the geographic impact of Sara C. Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara C. Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara C. Singer more than expected).

Fields of papers citing papers by Sara C. Singer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara C. Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara C. Singer. The network helps show where Sara C. Singer may publish in the future.

Co-authorship network of co-authors of Sara C. Singer

This figure shows the co-authorship network connecting the top 25 collaborators of Sara C. Singer. A scholar is included among the top collaborators of Sara C. Singer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara C. Singer. Sara C. Singer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Harvey, Richard J., Kevin Brown, Qin Zhang, et al.. (2009). GSK983: A novel compound with broad-spectrum antiviral activity. Antiviral Research. 82(1). 1–11. 52 indexed citations
2.
Cwirla, Steven E., Balasubramanian Palaniappan, Sara C. Singer, et al.. (1997). Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural Cytokine. Science. 276(5319). 1696–1699. 339 indexed citations
3.
Mullin, Robert J., Barry R. Keith, Eric C. Bigham, et al.. (1992). In vivo antitumor activity and metabolism of a series of 5-deazaacyclotetrahydrofolate (5-DACTHF) analogues. Biochemical Pharmacology. 43(7). 1627–1634. 11 indexed citations
4.
Lee, Richard F., Sara C. Singer, & David S. Page. (1981). Responses of cytochromeP-450 systems in marine crab and polychaetes to organic pollutants. Aquatic Toxicology. 1(5-6). 355–365. 53 indexed citations
5.
Singer, Sara C., et al.. (1981). Purification scheme for cytochrome P-450 of blue crab callinectes sapidus rathbun. Aquatic Toxicology. 1(5-6). 271–278. 7 indexed citations
6.
Singer, Sara C., et al.. (1980). Mixed function oxygenase activity in the blue crab, Callinectes Sapidus: characterization of enzyme activity from stomach tissue. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 65(2). 129–134. 32 indexed citations
7.
Singer, Sara C. & Richard F. Lee. (1977). MIXED FUNCTION OXYGENASE ACTIVITY IN BLUE CRAB,CALLINECTES SAPIDUS:TISSUE DISTRIBUTION AND CORRELATION WITH CHANGES DURING MOLTING AND DEVELOPMENT. Biological Bulletin. 153(2). 377–386. 52 indexed citations
8.
Singer, Sara C. & E W Holmes. (1977). Human glutamine phosphoribosylpyrophosphate amidotransferase. Hysteretic properties.. Journal of Biological Chemistry. 252(22). 7959–7963. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026